FWBI - First Wave BioPharma surges on plans to sell niclosamide program
2023-12-27 07:43:36 ET
More on First Wave BioPharma
- First Wave BioPharma files for stock and warrants offering, size not disclosed
- First Wave BioPharma CFO discloses sale of 1,676 shares
- Seeking Alpha’s Quant Rating on First Wave BioPharma
- Historical earnings data for First Wave BioPharma
- Financial information for First Wave BioPharma
For further details see:
First Wave BioPharma surges on plans to sell niclosamide program